News
Wegovy is now positioned as the first and only GLP-1 treatment.
The initiative aims to identify and support new ideas for innovative oral formulations for peptide drugs such as GLP-1 ...
FDA states substantial evidence of efficacy was not demonstrated.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback